Status: Not yet recruiting
Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
Study of QUAIL-100 in Patients With High Risk Acute Leukemia and Myelodysplastic Syndrome Who Have Received Hematopoietic Stem Cell Transplant
Participants needed: 12
Trial details
Phase: Phase 1Age: 18-39Biological sex: AllType: InterventionalSponsor: Laguna Biotherapeutics, Inc.Updated: May 13, 2026Locations: 1
Eligibility criteria
Weight >/= 10 kg [+3]
Active Grade II acute graft versus host disease (aGVHD) requiring > 0.5 mg/kg me... [+7]